We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Proposes to Reclassify Melanoma Detection Devices and Electrical Impedance Spectrometers
FDA Proposes to Reclassify Melanoma Detection Devices and Electrical Impedance Spectrometers
The FDA is proposing to reclassify two high-risk, class III devices — optical diagnostic devices for melanoma detection and electrical impedance spectrometers — into class II (special controls) subject to 510(k) clearance.